vs

Side-by-side financial comparison of OMNICELL, INC. (OMCL) and Tradeweb Markets Inc. (TW). Click either name above to swap in a different company.

Tradeweb Markets Inc. is the larger business by last-quarter revenue ($617.8M vs $309.9M, roughly 2.0× OMNICELL, INC.). Tradeweb Markets Inc. runs the higher net margin — 37.7% vs 3.7%, a 34.1% gap on every dollar of revenue. On growth, Tradeweb Markets Inc. posted the faster year-over-year revenue change (21.2% vs 14.9%). OMNICELL, INC. produced more free cash flow last quarter ($38.6M vs $2.0M). Over the past eight quarters, Tradeweb Markets Inc.'s revenue compounded faster (23.5% CAGR vs 5.8%).

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

Tradeweb Markets Inc., headquartered in New York City, operates electronic trading platforms primarily used by institutional investors to trade fixed income products, ETFs, and derivatives. It has over 3,000 customers including banks, asset managers, central banks, pension funds, and insurance companies. In 2024, 83% of the company's revenue was from transaction fees and commissions and 17% was from subscription fees. In 2024, 52% of revenue came from products related to rates, 27% of revenue...

OMCL vs TW — Head-to-Head

Bigger by revenue
TW
TW
2.0× larger
TW
$617.8M
$309.9M
OMCL
Growing faster (revenue YoY)
TW
TW
+6.3% gap
TW
21.2%
14.9%
OMCL
Higher net margin
TW
TW
34.1% more per $
TW
37.7%
3.7%
OMCL
More free cash flow
OMCL
OMCL
$36.6M more FCF
OMCL
$38.6M
$2.0M
TW
Faster 2-yr revenue CAGR
TW
TW
Annualised
TW
23.5%
5.8%
OMCL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
OMCL
OMCL
TW
TW
Revenue
$309.9M
$617.8M
Net Profit
$11.4M
$233.2M
Gross Margin
45.3%
Operating Margin
60.1%
46.5%
Net Margin
3.7%
37.7%
Revenue YoY
14.9%
21.2%
Net Profit YoY
38.5%
EPS (diluted)
$0.25
$0.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OMCL
OMCL
TW
TW
Q1 26
$309.9M
$617.8M
Q4 25
$314.0M
$521.2M
Q3 25
$310.6M
$508.6M
Q2 25
$290.6M
$513.0M
Q1 25
$269.7M
$509.7M
Q4 24
$306.9M
$463.3M
Q3 24
$282.4M
$448.9M
Q2 24
$276.8M
$405.0M
Net Profit
OMCL
OMCL
TW
TW
Q1 26
$11.4M
$233.2M
Q4 25
$325.0M
Q3 25
$5.5M
$185.6M
Q2 25
$5.6M
$153.8M
Q1 25
$-7.0M
$148.4M
Q4 24
$142.2M
Q3 24
$8.6M
$113.9M
Q2 24
$3.7M
$119.2M
Gross Margin
OMCL
OMCL
TW
TW
Q1 26
45.3%
Q4 25
41.5%
Q3 25
43.3%
Q2 25
43.9%
Q1 25
41.1%
Q4 24
46.2%
Q3 24
43.3%
Q2 24
41.3%
Operating Margin
OMCL
OMCL
TW
TW
Q1 26
60.1%
46.5%
Q4 25
0.1%
42.4%
Q3 25
2.7%
41.4%
Q2 25
2.8%
39.0%
Q1 25
-4.3%
40.0%
Q4 24
4.0%
40.7%
Q3 24
2.3%
35.5%
Q2 24
1.2%
40.1%
Net Margin
OMCL
OMCL
TW
TW
Q1 26
3.7%
37.7%
Q4 25
62.4%
Q3 25
1.8%
36.5%
Q2 25
1.9%
30.0%
Q1 25
-2.6%
29.1%
Q4 24
30.7%
Q3 24
3.1%
25.4%
Q2 24
1.3%
29.4%
EPS (diluted)
OMCL
OMCL
TW
TW
Q1 26
$0.25
$0.96
Q4 25
$-0.05
$1.52
Q3 25
$0.12
$0.86
Q2 25
$0.12
$0.71
Q1 25
$-0.15
$0.69
Q4 24
$0.34
$0.66
Q3 24
$0.19
$0.53
Q2 24
$0.08
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OMCL
OMCL
TW
TW
Cash + ST InvestmentsLiquidity on hand
$239.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
Total Assets
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OMCL
OMCL
TW
TW
Q1 26
$239.2M
Q4 25
$196.5M
$2.1B
Q3 25
$180.1M
$1.9B
Q2 25
$399.0M
$1.6B
Q1 25
$386.8M
$1.3B
Q4 24
$369.2M
$1.3B
Q3 24
$570.6M
$1.2B
Q2 24
$556.8M
$1.7B
Stockholders' Equity
OMCL
OMCL
TW
TW
Q1 26
$1.3B
Q4 25
$1.2B
$6.5B
Q3 25
$1.2B
$6.3B
Q2 25
$1.3B
$6.1B
Q1 25
$1.3B
$5.9B
Q4 24
$1.2B
$5.8B
Q3 24
$1.2B
$5.7B
Q2 24
$1.2B
$5.6B
Total Assets
OMCL
OMCL
TW
TW
Q1 26
$2.0B
Q4 25
$2.0B
$8.2B
Q3 25
$1.9B
$8.0B
Q2 25
$2.1B
$8.1B
Q1 25
$2.2B
$7.4B
Q4 24
$2.1B
$7.3B
Q3 24
$2.3B
$7.3B
Q2 24
$2.3B
$7.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OMCL
OMCL
TW
TW
Operating Cash FlowLast quarter
$54.5M
Free Cash FlowOCF − Capex
$38.6M
$2.0M
FCF MarginFCF / Revenue
12.5%
0.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
4.80×
TTM Free Cash FlowTrailing 4 quarters
$110.8M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OMCL
OMCL
TW
TW
Q1 26
$54.5M
Q4 25
$30.4M
$355.9M
Q3 25
$28.3M
$342.3M
Q2 25
$42.8M
$409.2M
Q1 25
$25.9M
$60.2M
Q4 24
$56.3M
$282.0M
Q3 24
$22.8M
$292.1M
Q2 24
$58.7M
$285.7M
Free Cash Flow
OMCL
OMCL
TW
TW
Q1 26
$38.6M
$2.0M
Q4 25
$22.6M
$336.5M
Q3 25
$18.5M
$328.3M
Q2 25
$31.0M
$403.7M
Q1 25
$14.8M
$58.6M
Q4 24
$47.2M
$256.8M
Q3 24
$13.9M
$287.8M
Q2 24
$49.1M
$280.8M
FCF Margin
OMCL
OMCL
TW
TW
Q1 26
12.5%
0.3%
Q4 25
7.2%
64.6%
Q3 25
6.0%
64.5%
Q2 25
10.7%
78.7%
Q1 25
5.5%
11.5%
Q4 24
15.4%
55.4%
Q3 24
4.9%
64.1%
Q2 24
17.8%
69.4%
Capex Intensity
OMCL
OMCL
TW
TW
Q1 26
Q4 25
2.5%
3.7%
Q3 25
3.1%
2.8%
Q2 25
4.1%
1.1%
Q1 25
4.1%
0.3%
Q4 24
3.0%
5.4%
Q3 24
3.1%
1.0%
Q2 24
3.5%
1.2%
Cash Conversion
OMCL
OMCL
TW
TW
Q1 26
4.80×
Q4 25
1.10×
Q3 25
5.18×
1.84×
Q2 25
7.58×
2.66×
Q1 25
0.41×
Q4 24
1.98×
Q3 24
2.64×
2.56×
Q2 24
15.72×
2.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

TW
TW

Transaction fees and commissions$523.8M85%
Subscription fees$60.3M10%
LSEG market data fees$26.7M4%

Related Comparisons